ストックスクリーナーアプリを入手
4.32
4.10%
0.17
アフターアワーズ：
4.30
-0.02
-0.46%
前日終値:
$4.15
開ける：
$4.07
24時間の取引高:
138.63K
Relative Volume:
0.05
時価総額：
$186.95M
収益：
-
当期純損益:
$-33.65M
株価収益率:
-0.9708
EPS:
-4.45
ネットキャッシュフロー:
$-20.83M
1週間 パフォーマンス:
+6.40%
1か月 パフォーマンス:
+12.50%
6か月 パフォーマンス:
+161.82%
1年 パフォーマンス:
+83.05%
1日の値動き範囲:
$4.05
$4.44
1週間の範囲:
$3.82
$4.44
52週間の値動き範囲:
$1.15
$12.46
Minerva Neurosciences Inc Stock (NERV) Company Profile
名前
Minerva Neurosciences Inc
セクター
電話
617-600-7373
住所
1500 DISTRICT AVENUE, BURLINGTON, MA
NERV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NERV
Minerva Neurosciences Inc
|
4.32 | 179.59M | 0 | -33.65M | -20.83M | -4.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Minerva Neurosciences Inc Stock (NERV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-06-08 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-05-14 | 開始されました | BTIG Research | Buy |
| 2019-10-02 | 繰り返されました | Chardan Capital Markets | Buy |
| 2019-09-25 | 開始されました | Chardan Capital Markets | Buy |
| 2019-09-18 | 開始されました | William Blair | Outperform |
| 2019-05-31 | 開始されました | H.C. Wainwright | Buy |
| 2017-09-01 | 開始されました | Citigroup | Buy |
| 2017-03-06 | 再開されました | Jefferies | Buy |
| 2016-05-12 | 再開されました | Jefferies | Buy |
すべてを表示
Minerva Neurosciences Inc (NERV) 最新ニュース
Minerva Neurosciences Inc (NERV) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Minerva Neurosciences (NASDAQ:NERV) Upgraded to "Hold" at Wall Street Zen - MarketBeat
Minerva Neurosciences (NASDAQ:NERV) & UCB (OTCMKTS:UCBJY) Head to Head Analysis - Defense World
Working capital per share of Minerva Neurosciences Inc – MUN:4MNA - TradingView — Track All Markets
Gains Recap: Why Minerva Neurosciences Inc stock is in analyst buy zoneProduct Launch & Free Expert Verified Stock Movement Alerts - moha.gov.vn
MSN Money - MSN
Published on: 2025-12-26 01:20:46 - moha.gov.vn
Reviewing Xenetic Biosciences (NASDAQ:XBIO) and Minerva Neurosciences (NASDAQ:NERV) - Defense World
Minerva Neurosciences shareholders approve key governance measures - MSN
Minerva Neurosciences Shareholders Approve Key Governance Measures - TipRanks
Risks Report: Why Minerva Neurosciences Inc. (4MNA) stock stays resilientMarket Activity Summary & Free High Accuracy Swing Entry Alerts - Улправда
Movement Recap: Why analysts upgrade Minerva Neurosciences Inc. stock2025 Growth vs Value & AI Powered Market Entry Ideas - Улправда
How strong is Minerva Neurosciences Inc. stock revenue growthGold Moves & Weekly High Return Forecasts - Улправда
Why analysts upgrade Minerva Neurosciences Inc. stockIndex Update & Risk Controlled Swing Alerts - Улправда
Is Minerva Neurosciences Inc. stock safe for conservative investorsJuly 2025 Fed Impact & Verified Stock Trade Ideas - DonanımHaber
What risks investors should watch in Minerva Neurosciences Inc. stock2025 Earnings Impact & Real-Time Volume Analysis - Улправда
Inderjit Kaul Net Worth (2025) - GuruFocus
Minerva Neurosciences (NERV) Price Target Increased by 12.50% to 4.59 - Nasdaq
Is Minerva Neurosciences Inc. stock a buy for dividend growth2025 EndofYear Setup & Safe Entry Zone Tips - Newser
How risky is Minerva Neurosciences Inc. (4MNA) stock compared to peersPortfolio Performance Report & Long Hold Capital Preservation Plans - Newser
How Minerva Neurosciences Inc. stock reacts to oil prices2025 Top Decliners & Technical Pattern Recognition Alerts - Newser
Minerva jumps on phase III funding, leading neuro stocks - BioWorld MedTech
Is Minerva Neurosciences Inc. stock attractive for retirement portfolios2025 Earnings Surprises & Capital Efficiency Focused Strategies - Newser
Minerva Neurosciences Stock Hits Near 2-Year High On FDA Pathway, $200M Boost — Retail Sees FDA Catalyst - MSN
Will Minerva Neurosciences Inc. (4MNA) stock boost dividends furtherSell Signal & Fast Exit and Entry Strategy Plans - Newser
Is Minerva Neurosciences Inc. (4MNA) stock cheap vs fundamentalsJuly 2025 Action & Verified Swing Trading Watchlist - Newser
Minerva Neurosciences (NERV) Stock Analysis Report | Financials & Insights - Benzinga
How Minerva Neurosciences Inc. (4MNA) stock compares with tech leadersJuly 2025 Weekly Recap & Stock Portfolio Risk Control - Newser
Market Fear: Why Minerva Neurosciences Inc 4MNA stock stays resilientJuly 2025 Outlook & Capital Efficiency Focused Ideas - moha.gov.vn
How Minerva Neurosciences Inc. stock trades during market volatilityJuly 2025 Catalysts & Free Low Drawdown Momentum Trade Ideas - moha.gov.vn
Performance Recap: What risks investors should watch in Minerva Neurosciences Inc. stock2025 Market Trends & Consistent Return Strategy Ideas - BỘ NỘI VỤ
Contrasting Minerva Neurosciences (NASDAQ:NERV) and Madrigal Pharmaceuticals (NASDAQ:MDGL) - Defense World
Is Transindia Real Estate Limited Undervalued or Overvalued Fair Value ExplainedTechnical Analysis Insights & Zero-Cost Stock Research by Professionals - earlytimes.in
Why Minerva Neurosciences Inc. stock appeals to analysts2025 Major Catalysts & Fast Gain Swing Trade Alerts - newser.com
Why Minerva Neurosciences Inc. (4MNA) stock attracts wealthy investorsPortfolio Growth Summary & High Conviction Buy Zone Picks - newser.com
Using Ichimoku Cloud for Minerva Neurosciences Inc. technicalsMarket Movers & Accurate Buy Signal Notifications - newser.com
Minerva Neurosciences Expands Board Amid Fundraising Effort - The Globe and Mail
Multi asset correlation models including Minerva Neurosciences Inc.July 2025 Big Picture & Weekly Top Gainers Alerts - newser.com
What to do if you’re stuck in Minerva Neurosciences Inc.Trade Signal Summary & Safe Capital Investment Plans - newser.com
Is Minerva Neurosciences Inc. stock vulnerable to regulatory risksForecast Cut & AI Forecast for Swing Trade Picks - newser.com
How buybacks impact Minerva Neurosciences Inc. stock valueEarnings Performance Report & Daily Oversold Stock Bounce Ideas - newser.com
Minerva Neurosciences Inc (NERV) 財務データ
収益
当期純利益
現金流量
EPS
2.52%
0.07%
大文字化:
|
ボリューム (24 時間):